• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Sep4
Citigroup Inc. Acquires Voting Rights in PureTech Health PLC
16:31
Aug29
PureTech Health released FY2025 Q1 earnings on August 28 (EST), actual revenue USD 925.5 K, actual EPS USD -0.95
03:00
Aug28
PureTech Health released FY2025 Q2 earnings on August 28 Pre-Market EST, actual revenue USD 925.5K, actual EPS USD -0.9499
13:30
PureTech Health released FY2025 Semi-Annual earnings on August 28 Pre-Market (EST), actual revenue USD 1.851 M (forecast USD 27.2 M), actual EPS USD -1.8999 (forecast USD -2.04)
13:30
Aug21
PureTech Health to release FY2025 Semi-Annual earnings on August 28, 2025 (EST), forecast revenue USD 27.2 M, EPS USD -2.04
00:11
Jul17
Seaport Therapeutics Initiates GlyphAlloTM Phase 2b Study for Major Depressive Disorder
11:06

Schedules & Filings

Schedules
Filings
Aug28
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 925.5 K, Net Income -22.3 M, EPS -0.9499

Apr30
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 2.27 M, Net Income 47.64 M, EPS 1.9433

Aug28
Earning Release(EST)

FY2024 Q2 Earning Release (USD) Revenue 144 K, Net Income -20.89 M, EPS -0.7745

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0280
+218.18%
+0.019
SMX
141.000
+141.07%
+82.510
PLRZ
14.500
+104.51%
+7.410
PMI
3.690
+82.67%
+1.670
SNCR
8.710
+64.34%
+3.410
PMCB
1.210
+54.22%
+0.425
QCLS
6.920
+48.18%
+2.250
ANPA
21.860
+40.67%
+6.320
HYNE
14.000
+40.00%
+4.000
ASTX
46.070
+36.50%
+12.320
View More